Bone disease

Vitamin D supplements advised with steroids

12 Jan 2012 0 comments

Most patients taking steroids have suboptimal vitamin D levels and should take supplements to prevent drug-induced osteoporosis, Australian experts advise.
Another reason to be cautious over calcium supplements?

8 Dec 2011 0 comments

The adverse effects of calcium supplementation attributed to MI are often gastrointestinal events, the latest study concludes, but calcium critic Associate Professor Ian Reid says the research gives another reason to be cautious over using the supplements for fracture prevention.
"Appalling gap" in osteoporotic fracture care

24 Nov 2011 0 comments

The health system is failing to manage patients with osteoporotic fractures and there is no excuse not to try and close the “appalling gap”, says a leading endocrinologist.
Some bisphosphonates may halve CRC risk: study

11 Aug 2011 0 comments

Risedronate appears to reduce the risk of colorectal cancer by 50%, preliminary research suggests.
Monitor bone health during anti-oestrogen treatment for breast cancer

9 Dec 2010 0 comments

The need to carefully monitor bone health and treat bone loss in women receiving anti-oestrogen therapy for breast cancer has been emphasised by a recent review in the Journal of Clinical Endocrinology and Metabolism.
$Call to fund fracture liaison services$
Call to fund fracture liaison services

2 Dec 2010 0 comments

Australian experts are calling on government to fund fracture liaison services after a Sydney study showed they can reduce the risk of another fracture by 80%.
$Thyroid dysfunction linked to hip fracture in men$
Thyroid dysfunction linked to hip fracture in men

24 Nov 2010 0 comments

Older men with thyroid dysfunction should be evaluated for hip fracture risk, say the authors of a large study that found both hyperthyroidism and hypothyroidism were independent predictors of hip fracture.
Search continues for key osteoporosis hormones

18 Nov 2010 0 comments

Inhibin has re-emerged as a key culprit in menopausal bone resorption and osteoporosis, following a study that has convincingly dismissed any major influence of follicle-stimulating hormone.
Aldosterone normal values need revision to reflect gender differences

28 Oct 2010 0 comments

Existing normal laboratory values for aldosterone activity should be revised to account for marked differences between men and women and the influence of the menstrual cycle, oral contraception and HRT, Brisbane researchers have claimed.
Childhood vitamin D supplementation unlikely to boost bone density

7 Oct 2010 0 comments

Vitamin D supplementation in healthy children has no effect on bone density and is therefore unlikely to influence the future risk of osteoporosis, an Australian-based Cochrane review has concluded.